Theophylline Nichiiko sustained release tablets 200 mg for asthma, bronchitis and emphysema

General information on Japanese Theophylline Nichiiko sustained release tablets 200 mg for asthma, bronchitis and emphysema

CURRENTLY UNAVAILABLE

Package details: 100 tablets

Manufacturer: Nichi-Iko Pharmaceutical Co., Ltd., Japan

Active ingredients: theophylline (chemical formula C7H8N4O2)

Medical effect: theophylline tablets are effective for the treatment of the following:

• bronchial asthma,
• asthmatic bronchitis,
• chronic bronchitis,
• emphysema.

Contraindications and precautions: do not use for pregnant or breastfeeding women. Avoid taking any food or supplements containing St. John's wort while taking this medicine. Smoking or cessation of smoking may affect the efficacy of this medicine. Intake of drinks containing much caffeine such as coffee or tea may cause side effects.

If an allergic reaction occurs, stop taking the medicine and consult with your doctor. If you’re taking any other medication or receiving any other treatment, you have to consult with your doctor before use.

Dosage and administration of Theophylline Nichiiko sustained release tablets 200 mg from Japan for asthma, bronchitis and emphysema

1. For adults: take 1 tablet (200 mg of the active ingredient) at a time, 2 times a day, in the morning and before bedtime.
2. For adults with bronchial asthma: the patient may take 2 tablets (400 mg) at a time once a day before bedtime.
3. For children: the dosage should be prescribed by the pediatrician in charge. When the medicine is taken on a feverish condition, blood concentration will increase and side effects can easily occur. Parents or guardians should observe the children's condition. If side effects occur, the dosage may need to be reduced or discontinued.

The doctor in charge may adjust the dosage according to disease, age and symptoms.

As this medicine is a sustained-release preparation, swallow it with water without chewing.

How effective are Theophylline Nichiiko sustained release tablets 200 mg from Japan for asthma, bronchitis and emphysema?

Theophylline is a xanthine derivative working as a phosphodiesterase inhibitor and a nonselective adenosine receptor antagonist. By this, it raises intracellular signal transduction, activates lipid metabolism and reduces inflammation by inhibiting inflammatory mediators and stabilizing the inflammatory response.

Who should use Theophylline Nichiiko sustained release tablets 200 mg from Japan?

Theophylline Nichiiko sustained release tablets 200 mg are effective for the treatment of bronchial asthma, asthmatic bronchitis, chronic bronchitis and emphysema. This medicine dilates bronchus and improves the symptoms of cough, sticky phlegm and respiratory distress. Studies showed that theophylline reduces requirements for inhaled corticosteroid therapy in patients with asthma (A. Markham, D. Faulds. “Theophylline. A review of its potential steroid sparing effects in asthma”. Drugs, 1998, 56(6): 1081-91).